Biocon Builds Biopharmaceutical Manufacturing Facility in Malaysia

Biotechnology company Biocon (Bangalore, India) says it has begun construction of a biopharmaceutical manufacturing and research and development facility in Bio-XCell, a custom-built biotechnology park and ecosystem in Iskandar Malaysia, in the state of Johor, Malaysia. Biocon will invest about $161 million in the first phase of construction of the facility, which is expected to become operational in 2014. The “The world-class infrastructure, fiscal and financial incentives, and the initiatives of the state government of Johor to promote bio-manufacturing...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers